Company / Operating Cash Flow per Share
Marker Therapeutics, Inc. Operating Cash Flow per Share History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.54
FY2021
5-year range
-$0.80 / -$0.40
FY2018-FY2021
Trend
-33.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.80 to $-0.54 over the past 3 years.
Based on SEC 10-K filings.
-0.54 in FY2021.
Improved from $-0.80 to $-0.54 over the past 3 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating cash flow per share decreased 33.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | -$0.54 | -33.6% |
| FY2019 | -$0.40 | +49.4% |
| FY2018 | -$0.80 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026